Physician profile
Joel Eric Michalak
NPI 1871167759
$2,698.62
in general payments reported to CMS, 2019-2025
12 companies · $2,699 in 2025
The $2,699 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,371 · Food and Beverage: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,371.35 |
| Food and Beverage | $1,327.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $1,784.08 | 2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $313.38 | 2025 | Ozempic, Wegovy |
| Dexcom, INC. | $185.16 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $119.40 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $95.93 | 2025 | Korlym |
| Neurocrine Biosciences, INC. | $61.19 | 2025 | |
| Beta Bionics, INC. | $40.42 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Abbott Laboratories | $23.71 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $20.50 | 2025 | Evenity |
| Mannkind Corporation | $19.74 | 2025 | |
| Inspire Medical Systems, INC. | $19.61 | 2025 | Inspire |
| Cequr Corporation | $15.50 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Michalak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.